Identification of additional dimerization partners of FIAT, the factor inhibiting ATF4-mediated transcription

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 208-215

  St Arnaud, René ^a,b   Elchaarani, Bilal ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

AP 1; C jun; FIAT; Fra 1; Osteoblast; Transcriptional repression

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; LEUCINE ZIPPER PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR FRA 1;

CELL ACTIVITY; CONFERENCE PAPER; DIMERIZATION; DNA SEQUENCE; ENZYME INHIBITION; GENETIC TRANSCRIPTION; OSTEOBLAST; OSTEOCALCIN GENE TRANSCRIPTION; PROTEIN BINDING; PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

EID: 37249006282     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.028     Document Type: Conference Paper

References (42)

1. WAGNER, E.F. 2002. Functions of AP1 (Fos/Jun) in bone development. Ann. Rheum. Dis. 61(Suppl 2): ii40-ii42.
2. YANG, X. & G. KARSENTY. 2002. Transcription factors in bone: developmental and pathological aspects. Trends Mol. Med. 8: 340-345.
3. HETTMANN, T., K. BARTON & J.M. LEIDEN. 2000. Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor. Dev. Biol. 222: 110-123.
4. MASUOKA, H.C. & T.M. TOWNES. 2002. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood 99: 736-745.
5. TANAKA, T. et al. 1998. Targeted disruption of ATF4 discloses its essential role in the formation of eye lens fibres. Genes Cells 3: 801-810.
6. YANG, X. et al. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117: 387-398.
7. ELEFTERIOU, F. et al. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520.
8. TRIVIER, E. et al. 1996. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384: 567-570.
9. ELEFTERIOU, F. et al. 2006. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab. 4: 441-451.
10. JOCHUM, W. et al. 2000. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6: 980-984.
11. ROSCHGER, P. et al. 2004. Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1. Bone 34: 776-782.
12. EFERL, R. et al. 2004. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23: 2789-2799.
13. KVEIBORG, M. et al. 2002. The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels. Endocrinology 143: 4304-4309.
14. KVEIBORG, M. et al. 2004. DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol. Cell Biol. 24: 2820-2830.
15. SABATAKOS, G. et al. 2000. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6: 985-990.
16. SIMS, N.A. et al. 2002. Regulating DeltaFosB expression in adult Tet-Off-DeltaFosB transgenic mice alters bone formation and bone mass. Bone 30: 32-39.
17. LANDSCHULZ, W.H., P.F. JOHNSON & S.L. MCKNIGHT. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240: 1759-1764.
18. GENTZ, R. et al. 1989. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science 243: 1695-1699.
19. GLOVER, J.N. & S.C. HARRISON. 1995. Crystal structure of the heterodimeric bZIP transcription factor c-Fos- c-Jun bound to DNA. Nature 373: 257-261.
20. VALLEJO, M. et al. 1993. C/ATF, a member of the activating transcription factor family of DNA- binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc. Natl. Acad. Sci. USA 90: 4679-4683.
21. HAI, T. & T. CURRAN. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88: 3720-3724.
22. CHEVRAY, P.M. & D. NATHANS. 1992. Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun. Proc. Natl. Acad. Sci. USA 89: 5789-5793.
23. HARTL, M., A.G. BADER & K. BISTER. 2003. Molecular targets of the oncogenic transcription factor jun. Curr. Cancer Drug Targets 3: 41-55.
24. VINSON, C. et al. 2002. Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell Biol. 22: 6321-6335.
25. MATSUO, K. et al. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24: 184-187.
26. VIAL, E. & C. J. MARSHALL. 2003. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J. Cell Sci. 116: 4957-4963.
27. YANG, X. & G. KARSENTY. 2004. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J. Biol. Chem. 279: 47109-47114.
28. GRUDA, M.C. et al. 1994. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9: 2537-2547.
29. CHINENOV, Y. & T.K. KERPPOLA. 2001. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20: 2438-2452.
30. FAWCETT, T.W. et al. 1999. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem. J. 339: 135-141.
31. LIM, C. et al. 2000. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J. Gen. Virol. 81: 2645-2652.
32. YU, V.W.C., C. GAUTHIER & R. ST- ARNAUD. 2006. Inhibition of ATF4 transcriptional activity by FIAT/g-taxilin modulates bone mass accrual. Ann. N. Y. Acad. Sci. 1068: 131-142.
33. YU, V.W. et al. 2005. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J. Cell Biol. 169: 591-601.
34. ST-ARNAUD, R. & V.W. YU. 2005. Inhibition of bone mass accrual by the FIAT transcriptional repressor. Med. Sci. (Paris). 21: 1020-1021.
35. SUDO, H. et al. 1983. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96: 191-198.
36. MOREAU, A. et al. 1998. Bone-specific expression of the alpha chain of the nascent polypeptide- associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol. Cell Biol. 18: 1312-1321.
37. QUELO, I., M. HURTUBISE & R. ST- ARNAUD. 2002. alphaNAC requires an interaction with c-Jun to exert its transcriptional coactivation. Gene Expr. 10: 255-262.
38. BAKIRI, L. et al. 2002. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell Biol. 22: 4952-4964.
39. AKHOUAYRI, O., I. QUELO & R. ST- ARNAUD. 2005. Sequence-specific DNA binding by the {alpha} NAC coactivator is required for potentiation of c-jun-dependent transcription of the osteocalcin gene. Mol. Cell Biol. 25: 3452-3460.
40. COHEN, D.R. et al. 1989. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev. 3: 173-184.
41. WISDON, R. & I.M. VERMA. 1993. Transformation by Fos proteins requires a Cterminal transactivation domain. Mol. Cell Biol. 13: 7429-7438.
42. YOSHIDA, K. et al. 2005. Interaction of the taxilin family with the nascent polypeptide-associated complex that is involved in the transcriptional and translational processes. Genes Cells 10: 465-476.